Loading...
The therapeutic potential of mTOR inhibitors in breast cancer
Rapamycin and modified rapamycins (rapalogs) have been used to prevent allograft rejection after organ transplant for over 15 years. The mechanistic target of rapamycin (mTOR) has been determined to be a key component of the mTORC1 complex which consists of the serine/threonine kinase TOR and at lea...
Na minha lista:
| Udgivet i: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061784/ https://ncbi.nlm.nih.gov/pubmed/27059645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12958 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|